Timothy M E Davis
01.09.2010
Helicobacter pylori cytotoxin-associated gene-A antibodies do not predict complications or death in type 2 diabetes: the Fremantle Diabetes Study
Schimke K, Chubb S, Davis W, Davis T. Helicobacter pylori cytotoxin-associated gene-A antibodies do not predict complications or death in type 2 diabetes: the Fremantle Diabetes Study. Atherosclerosis 2010; 212:321-6.
01.09.2010Helicobacter pylori cytotoxin-associated gene-A antibodies do not predict complications or death in type 2 diabetes: the Fremantle Diabetes Study
01.09.2010Atherosclerosis 2010; 212:321-6
Schimke Katrin-Elisabeth, Chubb Stephen A P, Davis Wendy A, Davis Timothy M E
Weiter
01.04.2007
Drug evaluation: rivoglitazone, a new oral therapy for the treatment of type 2 diabetes
Schimke K, Davis T. Drug evaluation: rivoglitazone, a new oral therapy for the treatment of type 2 diabetes. Current opinion in investigational drugs (London, England : 2000) 2007; 8:338-44.
01.04.2007Drug evaluation: rivoglitazone, a new oral therapy for the treatment of type 2 diabetes
01.04.2007Current opinion in investigational drugs (London, England : 2000) 2007; 8:338-44
Schimke Katrin-Elisabeth, Davis Timothy M E
Weiter